BING-NEEL SYNDROME

This adverse event was reported 39 times

BING-NEEL SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CHLORAMBUCIL 2 0.0005
1 ZANUBRUTINIB 2 0.0004
2 IBRUTINIB 24 0.0003
3 BENDAMUSTINE HCL 4 0.0003
4 RITUXIMAB 23 0.0001
5 MEPERIDINE HYDROCHLORIDE 1 0.0001
6 DEXAMETHASONE SODIUM PHOSPHATE 1 0.0001
7 CYTARABINE 5 0.0001
8 THEOPHYLLINE ANHYDROUS 1 0.0001
9 BORTEZOMIB 5 0.0001
See all drugs enriched for association with BING-NEEL SYNDROME

BING-NEEL SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD20-directed Cytolytic Antibody [EPC] 23 0.0001
1 Kinase Inhibitor [EPC] 26 0.0000
2 Proteasome Inhibitor [EPC] 5 0.0000
3 Provitamin D2 Compound [EPC] 1 0.0000
4 BCL-2 Inhibitor [EPC] 2 0.0000
5 Topoisomerase Inhibitor [EPC] 2 0.0000
6 Alkylating Drug [EPC] 6 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 10 0.0000
8 Nucleoside Metabolic Inhibitor [EPC] 5 0.0000
9 Methylxanthine [EPC] 1 0.0000
See all drug classes enriched for association with BING-NEEL SYNDROME